Page last updated: 2024-10-25

deferoxamine and Paranasal Sinus Diseases

deferoxamine has been researched along with Paranasal Sinus Diseases in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Paranasal Sinus Diseases: Diseases affecting or involving the PARANASAL SINUSES and generally manifesting as inflammation, abscesses, cysts, or tumors.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ammon, A1
Rumpf, KW1
Hommerich, CP1
Behrens-Baumann, W1
RĂ¼chel, R1
Anand, VK1
Alemar, G1
Griswold, JA1

Reviews

1 review available for deferoxamine and Paranasal Sinus Diseases

ArticleYear
Intracranial complications of mucormycosis: an experimental model and clinical review.
    The Laryngoscope, 1992, Volume: 102, Issue:6

    Topics: Adult; Alloxan; Amphotericin B; Animals; Brain Abscess; Brain Diseases; Child; Deferoxamine; Diabete

1992

Other Studies

1 other study available for deferoxamine and Paranasal Sinus Diseases

ArticleYear
[Rhinocerebral mucormycosis during deferoxamine therapy].
    Deutsche medizinische Wochenschrift (1946), 1992, Sep-18, Volume: 117, Issue:38

    Topics: Adult; Blindness; Brain Diseases; Cellulitis; Combined Modality Therapy; Deferoxamine; Female; Human

1992